Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,757 | -2,751 | -442 | -991 | -790 |
| Depreciation Amortization | 1 | 1 | 1 | 5 | 3 |
| Accounts receivable | 310 | 536 | 697 | -735 | N/A |
| Accounts payable and accrued liabilities | -898 | -913 | -983 | 969 | 215 |
| Other Working Capital | -1,215 | -669 | -556 | 416 | 327 |
| Other Operating Activity | 2,354 | 1,515 | 312 | -141 | -180 |
| Operating Cash Flow | $-3,205 | $-2,282 | $-970 | $-477 | $-424 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 530 | 530 |
| Common Stock Issued | 12,034 | 12,034 | 12,084 | N/A | N/A |
| Other Financing Activity | 9 | 9 | 5 | -87 | -85 |
| Financing Cash Flow | $12,044 | $12,044 | $12,089 | $443 | $445 |
| Beginning Cash Position | 2 | 2 | 2 | 35 | 35 |
| End Cash Position | 8,841 | 9,763 | 11,121 | 2 | 56 |
| Net Cash Flow | $8,839 | $9,761 | $11,119 | $-34 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,205 | -2,282 | -970 | -477 | -424 |
| Free Cash Flow | -3,205 | -2,282 | -970 | -477 | -424 |